Lipoprotein (a) and its role in atherothrombotic disease
Howard, G.C.; Pizzo, S.V.
Laboratory Investigation; a Journal of Technical Methods and Pathology 69(4): 373-386
1993
ISSN/ISBN: 0023-6837 PMID: 8231106 Document Number: 420255
Document emailed within 1 workday
Related Documents
Hansen, P.R. 2006: High-density lipoprotein: a new target in the battle against atherothrombotic disease Ugeskrift for Laeger 168(5): 468-470Cheng, T.O. 1993: Lipoprotein(a) and its role in occlusive vascular disease Annals of the Royal College of Surgeons of England 75(4): 299-300
Tennant, M.; McGeachie, J.K. 1993: Lipoprotein(a) and its role in occlusive vascular disease Annals of the Royal College of Surgeons of England 75(1): 3-7
Ahlehoff, O.; Gislason, G.H.; Skov, L.; Hansen, P.R. 2010: Psoriasis and atherothrombotic disease Ugeskrift for Laeger 172(26): 1983-1986
Blann, A.D.; Lip, G.Y. 1998: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(4): 297-306
Takahashi, W. 2006: Association between intra- and extra-cranial large vessel disease in atherothrombotic infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl. 8: 116-119
Collet, J.P.; Allali, Y.; Borentain, M.; Payot, L.; Raoux, F.; Cacoub, P.; Leys, D.; Alperovitch, A.; Montalescot, G. 2005: Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease Archives des Maladies du Coeur et des Vaisseaux 98 Spec no 4: 31-54
Bóngard, V.; Cambou, J.P.; Coppe, G.; Jullien, G.; Vahanian, A.; Mas, J.L. 2003: Prevalence and management of patients with a prior history of atherothrombotic disease in primary care in France. Results of the ECLAT1 survey Archives des Maladies du Coeur et des Vaisseaux 96(9): 833-840
Weber, M.; McNicoll, S.; Marcil, M.; Connelly, P.; Lussier-Cacan, S.; Davignon, J.; Latour, Y.; Genest, J. 1997: Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians Canadian Journal of Cardiology 13(3): 253-260
Matsuda, Y. 1993: High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation Kobe Journal of Medical Sciences 39(1): 1-14
Fruchart, J.C.; Duriez, P. 1995: The important role of apolipoprotein C-IIi in lipoprotein metabolism Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 189(5): 889-897
Wandzilak, M.; Jodłowski, J. 1991: Role of lipoprotein (a) in the development of atherosclerosis and formation of thrombi Polski Tygodnik Lekarski 46(37-39): 720-721
Mehta, J.L. 2004: The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis Canadian Journal of Cardiology 20(Suppl): 32b-36b
Vinogradov, A.G.; Alksnis, E.G.; Nagornev, V.A.; Kuznetsov, A.S.; Andreeva, L.I. 1976: Role of foam cells in lipoprotein transformation within the vascular wall Kardiologiia 16(2): 37-41
Bruckert, E.; Giral, P.; Dairou, F.; De Gennes, J.L. 1988: High-density cholesterol lipoprotein: metabolism and role in atherosclerosis Presse Medicale 17(17): 862-866
Yoshida, Y. 2006: Pathophysiology of atherothrombotic infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 97-101
Fruchart, J.C.; Ailhaud, G. 1992: Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance Clinical Chemistry 38(6): 793-797
Zorzon, M.; Iona, L.G.; Masè, G.; Cazzato, G. 1986: The hematocrit and atherothrombotic cerebral infarcts Rivista di Neurologia 56(5): 300-310
Hoshino, H. 2006: Treatment and prognosis of the atherothrombotic cerebral infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 120-125
Birjmohun, R.S.; van der Steeg, W.A.; Stroes, E.S.G.; Kastelein, J.J.P. 2006: The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations Nederlands Tijdschrift Voor Geneeskunde 150(41): 2245-2250